Anna Goodman


Consultant in infectious diseases and general medicine


Anna Goodman is a consultant in infectious diseases and general (internal) medicine. She has been a consultant at Guy's and St Thomas' since 2014 and also works at the MRC clinical trials unit at UCL as an associate professor. Anna runs a general infectious diseases clinic on Thursday afternoons. She also supports a dermatology/infectious diseases specialist clinic.

Anna specialises in clinical trials in infectious diseases. She has been the local principal investigator for a number of vaccine trials in malaria and more recently COVID-19.

Anna trained in medicine at Oxford University and the University of London.

Education and training

  • DPhil
  • MRCP (infectious diseases)
  • FRCP
  • FRCPath
  • DipHIV
  • DTM&H
  • MA (Oxon)
  • MBBS (Oxford University and University College London)

Research interests

  • Vaccines and COVID-19
  • Vaccines and malaria
  • Imaging and infection
  • Staphylococcus aureus (S. aureus) bacteraemia

  • Antibiotic selection, duration and usage in infection


Key recent publications

Treatment of methicillin-resistant Staphylcoccus aureus (MRSA): updated guidelines from the UK J Antimicrobial Chemo in press

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Voysey et al.  Lancet 8th Dec 2020

Remdesivir for the Treatment of Covid-19 — N Engl J Med 2020; 383:1813-1826

Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2018 391(10121):668-678

Last updated: April 2022

Is this page useful?